Corient Capital Partners’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-77,824
Closed -$685K 716
2022
Q1
$685K Buy
77,824
+1,152
+2% +$9.12K 0.05% 319
2021
Q4
$542K Sell
76,672
-8,619
-10% -$68.8K 0.04% 353
2021
Q3
$799K Buy
85,291
+8,299
+11% +$65.8K 0.06% 254
2021
Q2
$693K Buy
76,992
+460
+0.6% +$3.7K 0.05% 291
2021
Q1
$547K Buy
+76,532
New +$527K 0.05% 300

Other funds holding FRO

Corient Capital Partners's FRO Position: Q2 2022 in Review

Corient Capital Partners sold out of Frontline (FRO) in Q2 2022, closing a stake of 77,824 shares — an estimated $685K sold.

Corient Capital Partners first reported a position in FRO in Q1 2021 and held it in 5 quarters. The position peaked at $799K in Q3 2021. 146 funds tracked by Wall St. Rank hold FRO as of Q2 2022.

  • Corient Capital Partners reported no remaining Frontline position as of Q2 2022 after selling out during the quarter.
  • Corient Capital Partners sold 77,824 Frontline shares in Q2 2022, an estimated $685K.
  • Corient Capital Partners first reported a position in Frontline in Q1 2021 and held it in 5 quarters.
  • Corient Capital Partners's Frontline position peaked at $799K in Q3 2021.
  • 146 funds tracked by Wall St. Rank held Frontline as of Q2 2022.

Based on Corient Capital Partners's 13F filing for Q2 2022, filed 12 Aug 2022.